MARKET

CSII

CSII

Cardiovascular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

32.37
+1.31
+4.22%
Opening 11:31 08/12 EDT
OPEN
31.65
PREV CLOSE
31.06
HIGH
32.49
LOW
31.65
VOLUME
49.95K
TURNOVER
--
52 WEEK HIGH
55.22
52 WEEK LOW
26.00
MARKET CAP
1.28B
P/E (TTM)
-41.0735
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CSII stock price target is 43.78 with a high estimate of 50.00 and a low estimate of 38.00.

EPS

CSII News

More
Cardiovascular Systems Inc (CSII) Q4 2020 Earnings Call Transcript
With me today are Scott Ward, CSI Chairman, President and Chief Executive Officer; Rhonda Robb, Operating Officer; Jeff Points, Chief Financial Officer; and Dr. Ryan Egeland, Chief Medical Officer. Approximately 30 minutes ago, we issued a press release annou
Motley Fool · 08/05 05:31
Cardiovascular Systems (CSII) Reports Q4 Loss, Tops Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 2.27% and 10.49%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 22:45
Cardiovascular Systems Sees Q1 Sales $55M-$58M vs $41.9M Estimate
Benzinga · 08/04 20:27
Cardiovascular Systems Q4 EPS $(0.43) Beats $(0.46) Estimate, Sales $42.50M Beat $38.31M Estimate
Cardiovascular Systems (NASDAQ:CSII) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.46) by 6.52 percent. This is a 1175 percent decrease over earnings of $0.04 per share
Benzinga · 08/04 20:26
Cardiovascular Systems, Inc. Reports Fiscal 2020 Fourth-Quarter Financial Results
CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2020 FOURTH-QUARTER FINANCIAL RESULTS
Business Wire · 08/04 20:05
Earnings Outlook for Cardiovascular Systems
Cardiovascular Systems (NASDAQ: CSII) releases its next round of earnings this Tuesday, August 04. Here's Benzinga's essential guide to Cardiovascular Systems's Q4 earnings report.Earnings and Revenue Cardiovascular Systems's EPS will be near $-0.46 on sales o
Benzinga · 08/03 16:48
Earnings Preview: Cardiovascular Systems (CSII) Q4 Earnings Expected to Decline
Cardiovascular Systems (CSII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/28 16:33
Cardiovascular Systems Presents REACH PVI Study at the New Cardiovascular Horizons Conference
CARDIOVASCULAR SYSTEMS PRESENTS REACH PVI STUDY AT THE NEW CARDIOVASCULAR HORIZONS CONFERENCE
Business Wire · 07/27 20:05

Industry

Medical Equipment, Supplies & Distribution
+1.65%
Healthcare Equipment & Supplies
+1.71%

Hot Stocks

Symbol
Price
%Change

About CSII

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.
More

Webull offers kinds of Cardiovascular Systems Inc stock information, including NASDAQ:CSII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CSII stock methods without spending real money on the virtual paper trading platform.